Skip to main content
. 2020 Aug 20;40(10):927–946. doi: 10.1007/s40261-020-00934-2

Table 2.

Summary of doravirine drug–drug interactions: the effect of concomitant drugs on doravirine pharmacokinetics

Concomitant medication dosing Doravirine dosing Doravirine GMR (90% CI) [(doravirine + concomitant medication)/doravirine alone] Reference
AUC0–∞ AUC0–24 Cmax C24
TDF 300 mg once daily Doravirine 100 mg SD 0.95 (0.80–1.12) 0.80 (0.64–1.01) 0.94 (0.78–1.12) [31]
TDF 300 mg + lamivudine 300 mg Doravirine 100 mg SD 0.96 (0.87–1.06) 0.97 (0.88–1.07) 0.94 (0.83–1.06) [31]
Efavirenz prior dosing 600 mg once daily Doravirine 100 mg SD (Day 1 following efavirenz cessation) 0.38 (0.33–0.45) 0.65 (0.58–0.73) 0.15 (0.10–0.23) [15]
Efavirenz prior dosing 600 mg once daily Doravirine 100 mg once daily (Day 14 following efavirenz cessation) 0.68 (0.58–0.80) 0.86 (0.77–0.97) 0.50 (0.39–0.64) [15]
Ritonavir 100 mg once daily Doravirine 50 mg SD 3.54 (3.04–4.11) 1.31 (1.17–1.46) 2.91 (2.33–3.62) [26]
Dolutegravir 50 mg once daily Doravirine 200 mg once daily 1.00 (0.89–1.12) 1.06 (0.88–1.28) 0.98 (0.88–1.09) [20]
Elbasvir 50 mg + grazoprevir 200 mg once daily Doravirine 100 mg once daily 1.56 (1.45–1.68) 1.41 (1.25–1.58) 1.61 (1.45–1.79) [27]
Ledipasvir 90 mg/sofosbuvir 400 mg SD Doravirine 100 mg SD 1.15 (1.07–1.24) 1.11 (0.97–1.27) 1.24 (1.13–1.36) [27]
Ketoconazole 400 mg once daily Doravirine 100 mg SD 3.06 (2.85–3.29) 1.25 (1.05–1.49) 2.75 (2.54–2.98) [26]
Rifampin 600 mg once daily Doravirine 100 mg SD 0.12 (0.10–0.15) 0.43 (0.35–0.52) 0.03 (0.02–0.04) [74]
Rifabutin 300 mg once daily Doravirine 100 mg SD 0.50 (0.45–0.55) 0.99 (0.85–1.15) 0.32 (0.28–0.35) [75]
Maintenance methadone 20–200 mg once daily Doravirine 100 mg once daily 0.74 (0.61–0.90) 0.76 (0.63–0.91) 0.80 (0.63–1.03) [30]
Antacid oral suspension (1600 mg aluminum hydroxide/1600 mg magnesium hydroxide/160 mg simethicone) SD Doravirine 100 mg SD 1.01 (0.92–1.11) 0.86 (0.74–1.01) 1.03 (0.94–1.12) [28]
Pantoprazole 40 mg once daily Doravirine 100 mg SD 0.83 (0.76–0.91) 0.88 (0.76–1.01) 0.84 (0.77–0.92) [28]

AUC024 area under the concentration–time curve from time zero to 24 h, AUC0 area under the concentration–time curve from time zero to infinity, C24 plasma concentration 24 h post-dose, CI confidence interval, Cmax maximum plasma concentration, GMR geometric mean ratio, SD single dose, TDF tenofovir disoproxil fumarate